TY - JOUR
T1 - Detection of recurrent colon cancer with In-111 labeled MoAb B72.3 in a patient with normal CEA and TAG-72 levels
AU - Vijayakumar, V.
AU - Blend, M. J.
AU - Johnson, D.
AU - Schnobrich, K.
AU - Golick, J.
PY - 1992/1/1
Y1 - 1992/1/1
N2 - The usefulness of radioimmunoscintigraphy with In-111 labeled MoAb B72.3 is illustrated in this case report of a patient with an aggressive cancer of the ascending colon. When used in conjunction with CT, ultrasound examination, and MRI, radioimmunoscintigraphy improved the specificity of these other imaging modalities, although the patient's serum CEA and TAG-72 levels remained within the normal ranges. In addition, MoAb imaging demonstrated superiority over CT in identifying an additional unsuspected lesion. Detection of occult disease by imaging modalities with or without elevated serum CEA levels is discussed.
AB - The usefulness of radioimmunoscintigraphy with In-111 labeled MoAb B72.3 is illustrated in this case report of a patient with an aggressive cancer of the ascending colon. When used in conjunction with CT, ultrasound examination, and MRI, radioimmunoscintigraphy improved the specificity of these other imaging modalities, although the patient's serum CEA and TAG-72 levels remained within the normal ranges. In addition, MoAb imaging demonstrated superiority over CT in identifying an additional unsuspected lesion. Detection of occult disease by imaging modalities with or without elevated serum CEA levels is discussed.
UR - http://www.scopus.com/inward/record.url?scp=0026752767&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0026752767&partnerID=8YFLogxK
U2 - 10.1097/00003072-199203000-00005
DO - 10.1097/00003072-199203000-00005
M3 - Article
C2 - 1611787
AN - SCOPUS:0026752767
SN - 0363-9762
VL - 17
SP - 180
EP - 184
JO - Clinical Nuclear Medicine
JF - Clinical Nuclear Medicine
IS - 3
ER -